VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV was delisted on the 7th of August, 2024.
11 hedge funds and large institutions have $19.7M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
10% more funds holding
Funds holding: 10 → 11 (+1)
9% more capital invested
Capital invested by funds: $18.1M → $19.7M (+$1.57M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$63.6K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$38.2K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$193K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$5K |
VBIV Hedge Fund Activity: Q4 2014 in Review
11 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) for Q4 2014, worth a combined $19.7M — up 8.7% from $18.1M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new VBIV positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $63.6K. The largest seller was Hudson Bay Capital Management, cutting an estimated $193K.
- 11 institutional investors held VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) as of Q4 2014, up from 10 in Q3 2014.
- Funds reported $19.7M of VBI Vaccines, Inc. New Common Stock (Canada) stock for Q4 2014, up 8.7% quarter-over-quarter.
- 3 funds opened new VBI Vaccines, Inc. New Common Stock (Canada) positions in Q4 2014 and 1 closed out, a net change of +2 holders.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) buyer in Q4 2014 was Goldman Sachs, an estimated $63.6K added.
- The largest VBI Vaccines, Inc. New Common Stock (Canada) seller in Q4 2014 was Hudson Bay Capital Management, an estimated $193K sold.
Based on aggregated 13F filings for Q4 2014.